Angelo Cascio Rizzo: CTA-Based Plaque RADS Improves Risk Stratification in ESUS
Angelo Cascio Rizzo, Vascular Neurologist at Niguarda Ca’ Granda Hospital, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“CTA-based Plaque RADS helps stratify non-stenotic carotid plaques in ESUS. New paper in Green Journal
Modified CTA-based Plaque RADS: practical, reproducible, everyday-applicable (k = 0.83)
High-risk Plaque RADS 3-4 in 21% of ESUS patients and strongly linked to stroke laterality (aOR 2.65)
ESUS with ipsilateral high-risk Plaque RADS showed:
- fewer competing cardioembolic sources (atrial cardiopathy, PFO, Afib)
- ~3-fold higher risk of ipsilateral stroke recurrence
Time for targeted prevention”
Title: CTA-Based Plaque-RADS to Assess Etiologic Role of Nonstenotic Carotid Plaques in Patients With Embolic Stroke of Undetermined Source
Authors: Angelo Cascio Rizzo, Ghil Schwarz, Simone Bellavia, Andrea Magi, Guglielmo C. Pero, Antonio Macera, Amedeo Cervo, Francesca Poggetti, Antonella Moreo, Valerio Tolva, Elio Clemente Agostoni, Mariangela Piano, Maria Sessa
Read the Full Article on Green Journal

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines
-
Nov 15, 2026, 20:50Asmaa Beltagy: Efficacy and Safety of Eltrombopag in SLE-Associated Immune Thrombocytopenia
-
Nov 15, 2026, 16:29Jean-Jacques Kiladjian: 20 Years of Interferon-Alpha Research in Myeloproliferative Neoplasms
-
Nov 15, 2026, 16:21Sukanto Paul: Why Platelet Transfusion Is Generally Avoided in TTP